NFKB1 and Graves disease: Previous studies in a murine model of Graves’ disease have shown that diosgenin can inhibit the proliferation of thyroid cells by inhibiting the expression of IGF-1, NF-κB, cyclin D1, and PCNA and alleviate goitre8,11.